NCT04843150View on ClinicalTrials.gov

Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study

CompletedOBSERVATIONAL

Enrollment

320

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

October 1, 2023

Conditions

Acute Lymphoblastic Leukemia

Trial Locations (2)

8200

Department of Pediatrics, Skejby Hospital, Aarhus

Aarhus University Hospital, Denmark, Aarhus N

All Listed Sponsors

lead

Aarhus University Hospital

OTHER

NCT04843150 - Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study | Biotech Hunter | Biotech Hunter